| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4935163 | Schizophrenia Research | 2016 | 5 Pages |
Abstract
Although there was no association of genotype with overall changes in BPRS scores, the greater improvement of negative symptoms in minor allele carriers indicates that rs2535629 may help to identify a subset of schizophrenia patients with better treatment response to clozapine. Therefore, our findings provide the first suggestive evidence that rs2535629 is relevant in antipsychotic response.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
E.J. Brandl, T.A. Lett, N.I. Chowdhury, A.K. Tiwari, G. Bakanidze, H.Y. Meltzer, S.G. Potkin, J.A. Lieberman, J.L. Kennedy, D.J. Müller,